Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
1
33%
Ph phase_3
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_3

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

NCT04895631
completedphase_2

18F-Fluorocholine for the Detection of Parathyroid Adenomas

NCT03764007
completednot_applicable

18F-fluorocholine and 18F-fluoride PET in Prostate Cancer

NCT04340765

Clinical Trials (3)

Showing 3 of 3 trials
NCT04895631Phase 3

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Completed
NCT03764007Phase 2

18F-Fluorocholine for the Detection of Parathyroid Adenomas

Completed
NCT04340765Not Applicable

18F-fluorocholine and 18F-fluoride PET in Prostate Cancer

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3